Follow The Filings

MGY

Earnings company data as of 9:46 AM ET 11/13

  • 1 of 1 EPS beats

History

1 period, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 4 Nov EPS 0.55 0.71 Beat +29.1%
Rev $475.3M $513.9M Beat +8.1%

Insider trades

Open-market buys and sales by MGY's executives, directors and 10% owners in the last 12 months, from their Form 4s

All MGY insider trades
  • $327K bought by 3 insiders
  • $10.8M sold by 7 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. David M. Khani Director
    Buy
    $1,446 54 shares at $26.78 +0.2% to stake
    Traded Sep 1 Filed Sep 3
  2. Ralph Lewis Ropp Director
    Buy
    $123K 5,000 shares at $24.63 +24% to stake
    Traded Aug 7 Filed Aug 11
  3. David M. Khani Director
    Buy
    $200K 8,000 shares at $25.00 +35% to stake
    Traded Aug 7 Filed Aug 11
  4. Shandell Szabo Director
    Buy
    $2,360 86 shares at $27.44 +0.4% to stake
    Traded Jun 1 Filed Jun 3
  5. Shandell Szabo Director
    Sale
    $375K 11,731 shares at $31.98 45% of stake
    Traded Mar 30 Filed Mar 31
  6. Brian Corales CFO
    Sale
    $961K 33,000 shares at $29.12 15% of stake
    Traded Mar 9 Filed Mar 11
  7. Arcilia Acosta Director
    Sale
    $560K 19,235 shares at $29.10 13% of stake
    Traded Mar 9 Filed Mar 11
  8. Timothy D. Yang EVP, Chief Legal & Comm & Sec
    Sale
    $4.4M 150,000 shares at $29.29 22% of stake
    Traded Mar 9 Filed Mar 11
  9. Christopher G. Stavros CEO
    Sale
    $3.5M 119,954 shares at $29.29 12% of stake
    Traded Mar 9 Filed Mar 11
  10. Dan F. Smith Director
    Sale
    $522K 18,000 shares at $29.01 13% of stake
    Traded Mar 9 Filed Mar 11
  11. Edward P. Djerejian Director
    Sale
    $522K 18,000 shares at $28.98 14% of stake
    Traded Mar 10 Filed Mar 11
  12. Ralph Lewis Ropp Director
    Buy
    $104K 4,500 shares at $23.10 +44% to stake
    Traded Nov 11, 2025 Filed Nov 12, 2025

Also filed in the last 12 months, not counted as buying or selling: 17 stock grants, 9 share withholdings for taxes, 3 sales back to the company, and 3 option exercises.

SEC filings

Recent issuer filings from EDGAR, 23 shown.

Filed Form Detail Links
SCHEDULE 13G/A —
SCHEDULE 13G —
10-Q
8-K 2.02,7.01,9.01
8-K 2.02,9.01
SCHEDULE 13G —
8-K 1.01,2.01,2.03,3.02,7.01,9.01
10-Q
8-K 2.02,7.01,9.01
8-K 1.01,2.03,9.01
SCHEDULE 13G/A —
8-K 8.01,9.01
424B5
8-K 8.01,9.01
8-K 8.01,9.01
8-K 1.01,2.03,3.02,7.01,9.01
8-K 8.01,9.01
424B5
SCHEDULE 13G —
8-K 5.07
10-Q
8-K 2.02,7.01,9.01
SCHEDULE 13G —

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf